$CING 4 SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: Silva Raul R., EVP and CSO Granted 4,293 Stock Option (right to Buy)
20 Jul 2026	Form 4: Schaffer Shane J., Director Granted 295,000 Stock Option (right to Buy)
20 Jul 2026	Form 4: Downey Bryan Wade, EVP & Chief Commercial Officer Granted 100,000 Stock Option (right to Buy)
20 Jul 2026	Form 4: Lawrence Bryan Jay, Director Granted 20,000 Stock Option (right to Buy)
20 Jul 2026	Form 4: Brams Matthew, EVP and Chief Medical Officer Granted 80,000 Stock Option (right to Buy)
20 Jul 2026	Form 4: Hargroves Thomas Jeffrey, Director Granted 20,000 Stock Option (right to Buy)
20 Jul 2026	Form 4: Callahan Jennifer L., EVP and CFO Granted 60,000 Stock Option (right to Buy)
20 Jul 2026	Form 4: Werth Peter J., Director Granted 20,000 Stock Option (right to Buy)
20 Jul 2026	Form 4: Silva Raul R., EVP and CSO Granted 80,000 Stock Option (right to Buy)
02 Jul 2026	Form 4: Silva Raul R., EVP and CSO Granted 3,885 Stock Option (right to Buy)
08 Jun 2026	Form 4: Hargroves Thomas Jeffrey, Director Bought 97,276 shares ($490K) · Acquired 77,821 Warrant to Purchase Common Stock (Open Market Purchase) ($7.78K) · Granted 15,000 Stock Option (right to Buy)
08 May 2026	Form 4: Silva Raul R., EVP and CSO Granted 3,422 Stock Option (right to Buy)
11 Mar 2026	Form 4: Silva Raul R., EVP and CSO Received 4,526 shares as a grant or award · Gave up 1,828 shares to cover exercise price or tax
11 Mar 2026	Form 4: Schaffer Shane J., Director Received 6,862 shares as a grant or award · Gave up 2,959 shares to cover exercise price or tax
11 Mar 2026	Form 4: Callahan Jennifer L., EVP and CFO Received 15,329 shares as a grant or award · Gave up 6,427 shares to cover exercise price or tax
11 Mar 2026	Form 4: Patel Nilay Dahyabhai, EVP, CLO and CCO Received 5,475 shares as a grant or award · Gave up 2,086 shares to cover exercise price or tax
11 Mar 2026	Form 4: Brams Matthew, EVP and Chief Medical Officer Received 4,526 shares as a grant or award · Gave up 1,025 shares to cover exercise price or tax
10 Feb 2026	Form 4: Werth Peter J., Director Bought 19,455 shares ($98.1K) · Acquired 15,564 Warrant to Purchase Common Stock (Open Market Purchase) ($1.56K)
10 Feb 2026	Form 4: Callahan Jennifer L., SVP and CFO Bought 4,864 shares ($24.5K) · Acquired 3,891 Warrant to Purchase Common Stock (Open Market Purchase) ($389)
10 Feb 2026	Form 4: Schaffer Shane J., Director Bought 6,809 shares ($34.3K) · Acquired 5,447 Warrant to Purchase Common Stock (Open Market Purchase) ($545)

Comments